The Role of Therapeutic Leukapheresis in Hyperleukocytotic AML

• Friederike Pastore ,

  * E-mail: Friederike.Pastore@med.uni-muenchen.de

  Affiliations Department of Internal Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich - Campus Groβhadern, Munich, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Alessandro Pastore,

  Affiliation Department of Internal Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich - Campus Groβhadern, Munich, Germany

  ⨯
• Georg Wittmann,

  Affiliation Department of Transfusion Medicine, University Hospital Munich, Ludwig-Maximilians-University Munich - Campus Groβhadern, Munich, Germany

  ⨯
• Wolfgang Hiddemann,

  Affiliations Department of Internal Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich - Campus Groβhadern, Munich, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Karsten Spiekermann

  Affiliations Department of Internal Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich - Campus Groβhadern, Munich, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯